Product Information
EFFERVESCENT ANTACID-PAIN RLF is a generic product labeled by Cardinal Health, priced at $0.0846 per EA under NDC 70000057401. Its NADAC has been published 84 times since Nov 20, 2024.
Strength
1000; 500; 1985 mg/1; mg/1; mg/1
Manufacturer
Cardinal HealthNDC
70000057401
Classification
Generic
Dosage Form
TABLET, EFFERVESCENT
Route
ORAL
Last Updated
9/17/2025
Active Ingredients
ANHYDROUS CITRIC ACID; ASPIRIN; SODIUM BICARBONATEApproval Type
OTC MONOGRAPH DRUG
FDA Application
M013On Market Since
6/25/2021
Pharmacological Classes
Price Statistics
The NADAC for EFFERVESCENT ANTACID-PAIN RLF has been published 84 times since Nov 20, 2024, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0846 per EA |
|---|---|
| All-time high | $0.0855 (May 14, 2025) |
| All-time low | $0.0837 (Dec 18, 2024) |
| 52-week high | $0.0847 |
| 52-week low | $0.0841 |
| Median price | $0.0846 |
| Average price | $0.0846 |
| Largest weekly change | -1.1% (Dec 18, 2024) |
| Weeks tracked | 84 |
| Tracking since | Nov 20, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the Aspirin, Citric Acid, Sodium Bicarbonate market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of EFFERVESCENT ANTACID-PAIN RLF?
The current National Average Drug Acquisition Cost (NADAC) for EFFERVESCENT ANTACID-PAIN RLF, manufactured by Cardinal Health, is $0.0846 per EA (NDC 70000057401), effective Jun 24, 2026.
How has the price of EFFERVESCENT ANTACID-PAIN RLF changed over time?
Over the history we have for it, the NADAC for EFFERVESCENT ANTACID-PAIN RLF has held within roughly two percent of its current level. It has been tracked across 84 weekly CMS publications since Nov 20, 2024.
What are the highest and lowest recorded NADAC prices for EFFERVESCENT ANTACID-PAIN RLF?
Since Nov 20, 2024, the NADAC for EFFERVESCENT ANTACID-PAIN RLF has ranged from a low of $0.0837 (Dec 18, 2024) to a high of $0.0855 (May 14, 2025), with a median of $0.0846 per EA.
Are there cheaper alternatives to EFFERVESCENT ANTACID-PAIN RLF?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of EFFERVESCENT ANTACID-PAIN RLF, so no direct lower-cost alternative is listed.
Who manufactures EFFERVESCENT ANTACID-PAIN RLF?
EFFERVESCENT ANTACID-PAIN RLF (NDC 70000057401) is labeled by Cardinal Health, and CMS classifies it as a generic product.
Related Drugs
Same classification